3 results
Approved WMOPending
The primary objective is to characterize the change in the Pharmacodynamic (PD) biomarker, fecal calprotectin, during treatment with anrukinzumab.The secondary objectives include:* Characterization of the PK profile and total IL-13 of three multiple…
Approved WMOCompleted
To assess variation in and between a small cohort of ACNES patients and healthy human volunteers.
Approved WMOCompleted
In this sub-study we will explore whether the inhibitory effects of conditioned stimuli depent on the subjective experience of pain. Furthermore, we will explore the time-frame of these inhibitory effects.